Safety And Efficacy Of Sirolimus-Eluting Stent System In All-Comers Real-World Population With Coronary Artery Stenosis: The Miles-Global Study

Martin Hudec,A. J. J. Ijsselmuiden,Ramiro Trillo,Hyeon-Cheol Gwon,Myung Ho Jeong,Yi-Chih Wang, Jose Marques Da Costa,In-Ho Chae,Min-Ji Charng,Oteh Maskon,Jose Moreu Burgos, G. Mayurathan, Hristo Mateev,Antonio Serra,Bela Merkely,Rita Theotonio,Chun Yao Huang, Samih Lawand,Philip Mar,Andriy Khokhlov, Beatriz Montilla, Mariano Valdes Chavarri, Mohammad Sadeghian

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2020）

引用 0|浏览8

暂无评分

摘要

The newer-generation ultrathin (<70-μm) strut drug-eluting stents have improved the outcomes by reducing the risk of restenosis, stent thrombosis, and myocardial infarction (MI) or possibly death as compared with second-generation thin-strut drug-eluting stents. Moreover, in the meriT-V trial, the

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要